Q2 2024 Arcutis Biotherapeutics Inc Earnings Call Transcript
Hello, and thank you for standing by. Welcome to our Arcutis Biotherapeutics Q2 2024 earnings call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to turn the call over to Latha Vairavan, Vice President, Finance, and Investor Relations. You may begin.
Thank you, Tywanda. Good afternoon, everyone, and thank you for joining us today to review our second quarter 2024 financial results and business update. Slides for today's call are available on the Investor section of the Arcutis website. On the call today are Frank Watanabe, President, and CEO; Patrick Burnett, Chief Medical Officer; Todd Edwards, Chief Commercial Officer; and David Topper, Chief Financial Officer.
I would like to remind everyone that we will be making forward-looking statements during this call. These statements are subject to certain risks and uncertainties, and our actual results may differ. We encourage you to review
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |